Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/16/1999 | EP0922462A2 Process for preparation of solid dosage forms |
06/16/1999 | EP0922457A1 Skin protection composition |
06/16/1999 | EP0922453A2 Percutaneous absorption type preparation containing tulobuterol |
06/16/1999 | EP0922451A2 Microcapsules containing seminal material for artificial insemination in pigs |
06/16/1999 | EP0922450A1 Effervescent preparation containing a plant extract |
06/16/1999 | EP0922449A2 Use of an enzymatically converted starch derivative as an encapsulating agent |
06/16/1999 | EP0922071A1 Polycarboxylic based cross-linked copolymers |
06/16/1999 | EP0921812A1 INSULIN PREPARATIONS CONTAINING NaCl |
06/16/1999 | EP0921811A2 Administration of histamine for therapeutic purposes |
06/16/1999 | EP0921810A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
06/16/1999 | EP0921808A1 Non-aqueous polar aprotic peptide formulations |
06/16/1999 | EP0921807A1 Hydrogenous medicament |
06/16/1999 | EP0921806A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders |
06/16/1999 | EP0921796A1 Tetrahydrolipstatin containing compositions |
06/16/1999 | EP0921795A1 An aqueous formulation comprising bambuterol and the use thereof |
06/16/1999 | EP0921793A1 Solid, non-deliquescent formulations of sodium valproate |
06/16/1999 | EP0921789A1 Taste masked liquid suspensions |
06/16/1999 | EP0921787A1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS |
06/16/1999 | EP0921786A1 Nasal administration of desmopressin |
06/16/1999 | EP0921774A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
06/16/1999 | EP0921756A1 Novel radiopharmaceutical compositions and matrices and uses thereof |
06/16/1999 | EP0873127A4 Anthelmintic macrocyclic lactone compositions |
06/16/1999 | EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
06/16/1999 | EP0836495A4 Delivery of oxygen-supersaturated physiologic solutions |
06/16/1999 | EP0689415B1 Low-viscosity cosmetic and pharmaceutical emulsions |
06/16/1999 | EP0581842B1 An organ specific emulsion |
06/16/1999 | CN2323783Y Nifedipine plaster film |
06/16/1999 | CN2323782Y Constant release paster for metoprolol |
06/16/1999 | CN2323781Y Order arrangement feeding apparatus for capsule |
06/16/1999 | CN1219967A Glial cell line-derived neurotrophic factor receptor |
06/16/1999 | CN1219924A Colchicine-skeleton compounds, their use as medicaments and compounds containing them |
06/16/1999 | CN1219919A Dissolvable oxides for biological applications |
06/16/1999 | CN1219879A Pharmaceutical compositions |
06/16/1999 | CN1219874A Preparation for percutaneous administration |
06/16/1999 | CN1219872A Compositions and method for treating or preventing diseases of body passageways |
06/16/1999 | CN1219429A Baby's mother health granulae and its processing method |
06/16/1999 | CN1219427A Local external-mounted medicament for curing angiitis and its preparation method |
06/16/1999 | CN1219426A Local external-mounted medicament for curing fracture and its preparation method |
06/16/1999 | CN1219424A Dandelion series health-care products |
06/16/1999 | CN1219422A Medicine for curing hepatic and gallbladder diseases |
06/16/1999 | CN1219420A External protection medicine for preventing schistosoma miracidium infection |
06/16/1999 | CN1219419A Cat-tail pollen pill |
06/16/1999 | CN1219411A Soft extract for relieving cough and asthma and its preparation method |
06/16/1999 | CN1219408A Capsule for tranquilization and vitalization |
06/16/1999 | CN1219401A Seahorse pain-eliminating ointment |
06/16/1999 | CN1219396A Gushifu-external application medicine for curing wind-cold syndrome |
06/16/1999 | CN1219393A Veterinary antiparasitic oil preparation oral liquid containing avilamycin or ivermectin |
06/16/1999 | CN1219391A Choline antagonist sticking preparation |
06/16/1999 | CN1219388A Comedo-extracting plastering sheet |
06/16/1999 | CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds |
06/15/1999 | US5912330 Sweeteners |
06/15/1999 | US5912271 Local anaesthetic agents, a polar lipid, a triacylglycerol and optionally water. |
06/15/1999 | US5912268 Dosage form and method for treating incontinence |
06/15/1999 | US5912239 Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules |
06/15/1999 | US5912225 Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same |
06/15/1999 | US5912017 Multiwall polymeric microspheres |
06/15/1999 | US5912016 Particles of crosslinked plant proteins and the process for their preparation |
06/15/1999 | US5912015 Drug delivery using time-release agent having zinc or magnesium salt dispersed in matrix; biodegradable |
06/15/1999 | US5912014 Oral salmon calcitonin pharmaceutical products |
06/15/1999 | US5912013 Drug delivery |
06/15/1999 | US5912012 Effervescent systems with simplified packaging requirements |
06/15/1999 | US5912011 Solvent system to be enclosed in capsules |
06/15/1999 | US5912010 Prophylactic and therapeutic treatment of skin sensitization and irritation |
06/15/1999 | US5912009 Fatty acid esters of glycolic acid and its salts |
06/15/1999 | US5912008 Laminated structure of backing layer, moisture and impermeable layer, tackifiers and permeation enhancer |
06/15/1999 | US5912007 Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same |
06/15/1999 | US5912006 Analgesics for menstruation pain |
06/15/1999 | US5912005 Methods of use of uncoated gel particles |
06/15/1999 | US5911972 Stable microbubbles suspensions injectable into living organisms |
06/15/1999 | US5911966 High surface area alumina solid |
06/15/1999 | US5911704 For delivering a pre-selected molecule into systemic circulation |
06/15/1999 | CA2201749C Stable aqueous alfa interferon solution formulations |
06/15/1999 | CA2161641C Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
06/15/1999 | CA2137363C Use of zona pellucida glycoproteins for immunocontraception |
06/10/1999 | WO1999027990A2 Stereospecific delivery of a drug using electrotransport |
06/10/1999 | WO1999027983A1 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml |
06/10/1999 | WO1999027981A1 Automatic liquid injection system and method |
06/10/1999 | WO1999027967A1 Therapeutic agents |
06/10/1999 | WO1999027961A1 Transdermal delivery of particulate vaccine compositions |
06/10/1999 | WO1999027960A1 Vaccine compositions for mucosal administration comprising chitosan |
06/10/1999 | WO1999027954A2 Mixed lipopeptide micelles for inducing an immune response |
06/10/1999 | WO1999027950A1 Compositions of leukaemia inhibitory factor |
06/10/1999 | WO1999027949A1 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE |
06/10/1999 | WO1999027946A1 Pharmaceutical composition comprising cyclosporin solid-state microemulsion |
06/10/1999 | WO1999027944A1 Prevention and treatment of amyloidogenic disease |
06/10/1999 | WO1999027941A1 Oral antioxidant preparation comprising selenium and reduced glutathione |
06/10/1999 | WO1999027940A1 Formulations for topical treatment of skin infections |
06/10/1999 | WO1999027922A1 The use of polyols in combating yeast infection and polyol preparations for said use |
06/10/1999 | WO1999027918A1 Microparticles for drug delivery across mucosa and the blood-brain barrier |
06/10/1999 | WO1999027917A1 Medicament preparation in the form of a tablet or pellet for acid-labile active substances |
06/10/1999 | WO1999027916A2 Method for producing solid dosing forms |
06/10/1999 | WO1999027915A1 Masking agent in powder form for pharmaceutical flavours |
06/10/1999 | WO1999027914A1 A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane for intramuscular administration |
06/10/1999 | WO1999027913A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
06/10/1999 | WO1999027912A1 Porous hydroxyapatite particles as carriers for drug substances |
06/10/1999 | WO1999027911A1 Soft-pellet drug and process for the preparation thereof |
06/10/1999 | WO1999027910A1 Microsphere reservoirs for controlled release application |
06/10/1999 | WO1999027909A1 Method for producing solid dosing forms |
06/10/1999 | WO1999027908A1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
06/10/1999 | WO1999027907A1 Improved method for avoiding the degradation of an active principle |